Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors.
Fiorini C, Massari F, Pedron S, Sanavio S, Ciccarese C, Porcaro AB, Artibani W, Bertoldo F, Zampini C, Sava T, Ficial M, Caliò A, Chilosi M, D'Amuri A, Sanguedolce F, Tortora G, Scarpa A, Delahunt B, Porta C, Martignoni G, Brunelli M.
Fiorini C, et al. Among authors: brunelli m.
Am J Cancer Res. 2014 Nov 19;4(6):907-15. eCollection 2014.
Am J Cancer Res. 2014.
PMID: 25520878
Free PMC article.